Thursday October 21



From vessel preparation to stenting : stay active!

  • Vessel preparation : an essential step to optimize your results. Gilles Goyault
  • The atherectomy : how and why JETSTREAM™ is the tool of choice in vessel preparation. The contribution of the imagery in the preparation of the vessel. Nicolas Louis
  • Let’s stay active : update on stenting and place of paclitaxel. What’s new in the landscape of clinical studies on the subject? Yann Gouëffic



Roadsaver : The Power of facts
Speaker: Koen Deloose

  • Introduction & Guideline
  • Patient Selection
  • Dual Layer Mesh technology & case presentation
  • Results of the latest clinical publication


  • Not every PAU has to be treated with an EVAR device. Nikolaos Tsilimparis
  • Finally towards on-label use of bridging stentgrafts in FEVAR: update of the BeGraft multicenter prospective study. Eric Verhoeven


Penumbra´s innovative solutions for Embolisation and Thrombectomy

Friday October 22


The role of external stenting in prevention of vein graft disease
Alexandros Mallios


Straight talk from the experts: Examining challenges and controversies in the treatment of long complex peripheral disease
Moderator: Yann Goueffic

Treatment of PAD with endoluminal bypass in long de novo lesions and in-stent restenosis with the Gore® Viabhan® endoprosthesis: Review of cases

  • De novo lesions clinical cases, Raphaël Coscas
  • Intra-stent restenosis clinical cases, Bahaa Nasr


Proven design for an off the shelf TAAA graft

  • Introduction and Moderator Bijan Modarai
  • How technical features can make a difference, Jonathan Sobocinski
  • Making complex easier for the emergent setting, Martin Austermann
  • Q&A



Truly minimally invasive peripheral interventions – tips and benefits of staying 4F


Could closure devices help develop ambulatory activities?


See clearly – Treat optimally

Moderator: Koen Deloose

  • How to define a calcified lesion? Fabrizio Fanelli
  • Rotational or laser atherectomy indications? Theodosios Bisdas
  • Contribution of IVUS in crossing CTO, Jérôme Brunet
  • Discussion